Our research group has been involved for a long time
in the development
of macrocyclic amidinoureas (MCAs) as antifungal agents. The mechanistic
investigation drove us to perform an in silico target
fishing study, which allowed the identification of chitinases as one
of their putative targets, with 1a showing a submicromolar
inhibition of Trichoderma viride chitinase. In this
work, we investigated the possibility to further inhibit the corresponding
human enzymes, acidic mammalian chitinase (AMCase) and chitotriosidase
(CHIT1), involved in several chronic inflammatory lung diseases. Thus,
we first validated the inhibitory activity of 1a against
AMCase and CHIT1 and then designed and synthesized new derivatives
aimed at improving the potency and selectivity against AMCase. Among
them, compound 3f emerged for its activity profile along
with its promising in vitro ADME properties. We also
gained a good understanding of the key interactions with the target
enzyme through in silico studies.